Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's website is Any material contained in or derived from the Company's websites or any other website is not part of this press release.Ĭertain statements contained in this press release, including, without limitation, statements containing the words ‘'believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. "Consumers looking to take advantage of the sports recovery benefits provided by AI Tape can purchase products, including our Active Intelligence AI Kinesiology Tape, on Amazon or through our Active Intelligence website."ĪI Tape is manufactured in the USA at the Company's Pocono Pharmaceutical facility in North Carolina. "We are very excited for the launch of our AI Tape brand, our first products targeting the consumer market," stated Gareth Sheridan, Nutriband CEO. AI Tape is designed to combine many of the traditional benefits of kinesiology tape with the addition of soothing and therapeutic ingredients held in suspension with a proprietary adhesive mix.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |